| |
 |
| Author |
Message |
|
|
|
Tue Dec 14, 2004 9:04 pm  |
Hi Ladies,
Please help! After reading good reviews about argireline, I'm thinking of trying it out, but I don't know which to try! I'm undecided between ADCE, Relaxaline and Judy's Esther's Secret, can someone give me the pros and cons of each?
I have oily skin and easily break out, Vitaminc C serum gives me cystic acne, thus I'm afraid ADCE will cause my skin to break out too? Can someone advise which of the three Argireline products is best for my skin (oily, acne)? I'm 37, don't have deep wrinkles yet and I want to start using Argireline to prevent them from forming ... Oh one more thing, my eyelids are starting to droop, which product is best in lifting them up? Will Okusil help?
Please advise, I'm desperate to look young!  |
|
|
|
|
|
Tue Dec 14, 2004 9:40 pm |
If your only problem area is around your eyes then OkuSil is the perfect stand-alone solution for you. Okusil is specially formulated with 10% Argireline to reduce puffiness and discoloration while firming under and above the eye area. Hyaluronic Acid will keep the eye area moist. DMAE, Collagen, Elastin, Soy Protein will address firmness while Vitamin K, Horse Chesnut Extract will address dark circles and puffiness.
AlphaDermaCE does not cause over stimulation of oil on your skin. Many woman put a moisturizer over it. Personally I think that the Okusil as a stand alone product would be fine for you.
Winnie
JB Sales Rep., Cape Cod, MA |
|
|
|
|
| Tue Apr 16, 2024 1:24 pm |
If this is your first visit to the EDS Forums please take the time to register. Registration is required for you to post on the forums. Registration will also give you the ability to track messages of interest, send private messages to other users, participate in Gift Certificates draws and enjoy automatic discounts for shopping at our online store. Registration is free and takes just a few seconds to complete.
Click Here to join our community.
If you are already a registered member on the forums, please login to gain full access to the site. |
|
 |
|
|
